Barclays maintains Alpha Tau Medical at Overweight, raises PT to $30
Barclays kept Alpha Tau Medical at Overweight and raised its price target to $30.00 per share from $17.00, according to Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.